Publication:
Clinical and Radiological Characteristics of Tumefactive Demyelinating Lesions: Follow-Up Study

dc.authorscopusid7006317905
dc.authorscopusid55292933000
dc.authorscopusid55958622900
dc.authorscopusid23062131200
dc.authorscopusid35104327800
dc.authorscopusid24330433300
dc.authorscopusid7005447791
dc.contributor.authorAltintaş, A.
dc.contributor.authorPetek, B.
dc.contributor.authorIşik, N.
dc.contributor.authorTerzi, M.
dc.contributor.authorBölükbaşı, F.
dc.contributor.authorTavsanli, M.
dc.contributor.authorSaip, S.
dc.date.accessioned2020-06-21T14:17:47Z
dc.date.available2020-06-21T14:17:47Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Altintaş] Ayşe, Department of Neurology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkey; [Petek] Belgin Balcï, Haseki Education and Research Hospital, Istanbul, Turkey; [Işik] Nihal N., T.C. Saglik Bakanligi Istanbul Goztepe Egitim ve Arastirma Hastanesi, Goztepe, Istanbul, Turkey; [Terzi] Murat, Department of Neurology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bölükbaşı] Feray, Department of Neurology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkey; [Tavsanli] Mustafa Emir, Department of Neurology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkey; [Saip] Sabahattin, Department of Neurology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkey; [Boz] Cavit, Department of Neurology, Karadeniz Technical University, Trabzon, Trabzon, Turkey; [Aydin] Tuǧrul, T.C. Saglik Bakanligi Istanbul Goztepe Egitim ve Arastirma Hastanesi, Goztepe, Istanbul, Turkey; [Arici-Duz] Özge Arıca, T.C. Saglik Bakanligi Istanbul Goztepe Egitim ve Arastirma Hastanesi, Goztepe, Istanbul, Turkey; [Özer] Feriha F., Haseki Education and Research Hospital, Istanbul, Turkey; [Siva] Aksel, Department of Neurology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkeyen_US
dc.description.abstractBackground: Demyelinating lesions over 20 mm in size, referred to as tumefactive demyelinating lesions, can be misdiagnosed as being either a tumor or an abscess. Although some radiological characteristics can help make a differential diagnosis easier, a cerebral biopsy may still be necessary.Objective: Our objective was to assess the clinical characteristics of tumefactive lesions, with or without a diagnosis of multiple sclerosis (MS), and present follow-up data for 54 patients with tumefactive lesions.Methods: Demographic, clinical, radiological and laboratory data were gathered and treatment responses were evaluated in a total of 54 patients from five medical centers.Result: Twenty-nine patients were diagnosed with tumefactive lesions at the onset, whereas 25 patients were diagnosed with tumefactive lesions after a diagnosis of MS. Median follow-up was 38.12 months. At final examination, 19 of the patients with a tumefactive lesion diagnosis at the onset eventually developed relapsing-remitting MS, while 10 remained with the condition as a clinically isolated syndrome. The tumefactive lesions studied were mostly focal, with closed-ring enhancement. We found that oligoclonal band positivity was less frequent in the patients with tumefactive onset.Conclusion: Although our demographic data were similar to formerly collected Turkish MS data, we found that the distribution of the patients' clinical course differed if there was an absence of primary progressive MS and that there was a lower frequency of secondary progressive MS cases in our group of patients. We believe that less frequent oligoclonal band positivity and the difference we witnessed in the clinical course of disease in our study groups suggest that there is a need for further studies to compare all the biological and immunological differences between MS and tumefactive lesion cases, in order to reveal whether there are different pathogenetic mechanisms involved. © The Author(s) 2012.en_US
dc.identifier.doi10.1177/1352458512438237
dc.identifier.endpage1453en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.issue10en_US
dc.identifier.pmid22419670
dc.identifier.scopus2-s2.0-84867030759
dc.identifier.scopusqualityQ1
dc.identifier.startpage1448en_US
dc.identifier.urihttps://doi.org/10.1177/1352458512438237
dc.identifier.volume18en_US
dc.identifier.wosWOS:000309359000013
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherinfo@sagepub.co.uken_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDemyelinating Diseaseen_US
dc.subjectMagnetic Resonance Imagingen_US
dc.subjectMultiple Sclerosisen_US
dc.subjectOligoclonal Bandingen_US
dc.subjectRelapsing-Remitting Multiple Sclerosisen_US
dc.subjectTumefactive Demyelinating Lesionen_US
dc.titleClinical and Radiological Characteristics of Tumefactive Demyelinating Lesions: Follow-Up Studyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files